[1
]
From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute,
St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto,
Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics
and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham
Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham,
AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and
University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability
Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre
for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD,
USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University
of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute;
Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and
Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.
beatond@smh.ca.
[2
]
D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St.
Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD,
Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and
Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH,
Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University
of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute
for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle
Quality of Life Group\Center for Disability Policy and Research, University of Washington;
L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs,
Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April,
BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and
Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc,
University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital
Research Institute, Clinical Epidemiology Program, University of Ottawa, Department
of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population
Health. beatond@smh.ca.
[3
]
From the Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute,
St Michael's Hospital, Toronto; Institute for Work & Health; University of Toronto,
Toronto, Canada; VU University Medical Centre, Department of Epidemiology and Biostatistics
and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands; Birmingham
Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham,
AL, USA; Women's College Hospital, Institute for Clinical Evaluative Sciences and
University of Toronto, Toronto, Canada; Seattle Quality of Life Group\Center for Disability
Policy and Research, University of Washington, Seattle, WA; Office of New Drugs, Centre
for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD,
USA; Department of Epidemiology and Community Medicine, Faculty of Medicine, University
of Ottawa; Department of Medicine, Faculty of Medicine, Ottawa Hospital Research Institute;
Clinical Epidemiology Program, University of Ottawa; Department of Epidemiology and
Community Medicine, Faculty of Medicine, Institute of Population Health, Ottawa, Canada.
[4
]
D.E. Beaton, BScOT, PhD, Senior Scientist Institute for Work & Health, Scientist St.
Michael's Hospital; Associate Professor, University of Toronto; C.B. Terwee, PhD,
Senior Epidemiologist, VU University Medical Centre, Department of Epidemiology and
Biostatistics and EMGO Institute for Health and Care Research; J.A. Singh, MBBS, MPH,
Associate Professor of Medicine, Birmingham Veterans Affairs Medical Center and University
of Alabama at Birmingham; G.A. Hawker, MD, MSc, FRCPC, Women's College Hospital, Institute
for Clinical Evaluative Sciences and University of Toronto; D.L. Patrick, PhD, Seattle
Quality of Life Group\Center for Disability Policy and Research, University of Washington;
L.B. Burke, RPh, MPH, Study Endpoints and Label Development, Office of New Drugs,
Centre for Drug Evaluation and Research, Food and Drug Administration; K. Toupin-April,
BScOT, PhD, Associate Scientist, Assistant Professor, Department of Epidemiology and
Community Medicine, Faculty of Medicine, University of Ottawa; P.S. Tugwell, MD, MSc,
University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa Hospital
Research Institute, Clinical Epidemiology Program, University of Ottawa, Department
of Epidemiology and Community Medicine, Faculty of Medicine, Institute of Population
Health.
